EDITORIAL
Published on 05 Jun 2024
Editorial: Gliomas microenvironment: new drug entities, mechanisms of action, molecular biomarkers and drug delivery strategies
doi 10.3389/fphar.2024.1431975
- 394 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Gliomas microenvironment: new drug entities, mechanisms of action, molecular biomarkers and drug delivery strategies
Gliomas microenvironment: new drug entities, mechanisms of action, molecular biomarkers and drug delivery strategies
10k
Total downloads
29k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 19 Apr 2024
Efficacy and Safety of Vaccines After Conventional Treatments for Survival of Gliomas: A Systematic Review and Meta-Analysis
doi 10.3389/or.2024.1374513
- 1,069 views
- 2 citations
TECHNOLOGY AND CODE
Published on 11 Apr 2024
ecGBMsub: an integrative stacking ensemble model framework based on eccDNA molecular profiling for improving IDH wild-type glioblastoma molecular subtype classification
doi 10.3389/fphar.2024.1375112
- 926 views
- 1 citation
REVIEW
Published on 08 Mar 2024
Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches
doi 10.3389/fphar.2024.1355242
- 3,714 views
- 6 citations
ORIGINAL RESEARCH
Published on 26 Feb 2024
TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
doi 10.3389/fimmu.2024.1356833
- 2,929 views
- 1 citation
ORIGINAL RESEARCH
Published on 16 Jan 2024
A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma
doi 10.3389/fphar.2023.1259051
- 2,510 views
- 1 citation
PERSPECTIVE
Published on 18 Dec 2023
Glioblastoma may evade immune surveillance through primary cilia-dependent signaling in an IL-6 dependent manner
doi 10.3389/fonc.2023.1279923
- 2,073 views
- 3 citations
ORIGINAL RESEARCH
Published on 20 Nov 2023
Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas
doi 10.3389/fphar.2023.1276466
- 1,756 views
- 4 citations
ORIGINAL RESEARCH
Published on 08 Nov 2023
Multi-omics analysis reveals CLIC1 as a therapeutic vulnerability of gliomas
doi 10.3389/fphar.2023.1279370
- 1,792 views
- 2 citations
REVIEW
Published on 30 Jun 2023
Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment
doi 10.3389/fphar.2023.1211719
- 3,678 views
- 15 citations
HYPOTHESIS AND THEORY
Published on 30 May 2023
Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?
doi 10.3389/fphar.2023.1156492
- 1,509 views
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore